Charlemagne Capital as of Dec. 31, 2013
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 51 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Baidu (BIDU) | 12.5 | $22M | 125k | 177.20 | |
| Banco Itau Holding Financeira (ITUB) | 11.3 | $20M | 1.5M | 13.59 | |
| Vale (VALE) | 10.5 | $19M | 1.2M | 15.25 | |
| CTC Media | 8.0 | $14M | 1.0M | 13.91 | |
| Banco Santander-Chile (BSAC) | 6.9 | $12M | 521k | 23.54 | |
| Petroleo Brasileiro SA (PBR.A) | 6.2 | $11M | 752k | 14.70 | |
| New Oriental Education & Tech | 5.8 | $10M | 328k | 31.51 | |
| Ambev Sa- (ABEV) | 5.5 | $9.9M | 1.3M | 7.35 | |
| Mobile TeleSystems OJSC | 5.5 | $9.8M | 453k | 21.63 | |
| Compania Cervecerias Unidas (CCU) | 4.7 | $8.4M | 350k | 24.09 | |
| Fomento Economico Mexicano SAB (FMX) | 4.4 | $7.8M | 80k | 97.75 | |
| Copa Holdings Sa-class A (CPA) | 3.2 | $5.7M | 36k | 159.92 | |
| Grupo Televisa (TV) | 2.8 | $5.1M | 167k | 30.32 | |
| Banco Bradesco SA (BBD) | 2.8 | $4.9M | 392k | 12.53 | |
| Credicorp (BAP) | 2.5 | $4.5M | 34k | 132.65 | |
| BRF Brasil Foods SA | 2.0 | $3.6M | 171k | 20.88 | |
| Grana Y Montero S A A | 1.8 | $3.3M | 154k | 21.24 | |
| Ultrapar Participacoes SA (UGP) | 0.6 | $1.0M | 44k | 23.61 | |
| Petroleo Brasileiro SA (PBR) | 0.6 | $1.0M | 74k | 13.79 | |
| Pfizer (PFE) | 0.3 | $519k | 17k | 30.66 | |
| Gerdau SA (GGB) | 0.3 | $457k | 58k | 7.84 | |
| Arrowhead Research | 0.2 | $403k | 37k | 10.84 | |
| Merck & Co (MRK) | 0.2 | $284k | 5.7k | 49.95 | |
| Johnson & Johnson (JNJ) | 0.1 | $275k | 3.0k | 91.42 | |
| Gilead Sciences (GILD) | 0.1 | $225k | 3.0k | 74.93 | |
| Abbvie (ABBV) | 0.1 | $199k | 3.8k | 52.88 | |
| Amgen (AMGN) | 0.1 | $157k | 1.4k | 113.77 | |
| Bristol Myers Squibb (BMY) | 0.1 | $143k | 2.7k | 52.96 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $144k | 2.7k | 53.33 | |
| Biogen Idec (BIIB) | 0.1 | $122k | 436.00 | 279.82 | |
| Allergan | 0.1 | $109k | 976.00 | 111.68 | |
| Illumina (ILMN) | 0.1 | $105k | 952.00 | 110.29 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $90k | 325.00 | 276.92 | |
| Medtronic | 0.1 | $94k | 1.6k | 57.28 | |
| Theravance | 0.1 | $90k | 2.5k | 35.50 | |
| Celgene Corporation | 0.1 | $95k | 563.00 | 168.74 | |
| Abbott Laboratories (ABT) | 0.0 | $64k | 1.7k | 38.25 | |
| Baxter International (BAX) | 0.0 | $78k | 1.1k | 69.58 | |
| Mylan | 0.0 | $63k | 1.5k | 43.42 | |
| Forest Laboratories | 0.0 | $67k | 1.1k | 60.25 | |
| Seattle Genetics | 0.0 | $29k | 718.00 | 40.39 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $31k | 446.00 | 69.51 | |
| Boston Scientific Corporation (BSX) | 0.0 | $33k | 2.8k | 11.95 | |
| Waters Corporation (WAT) | 0.0 | $32k | 315.00 | 101.59 | |
| Life Technologies | 0.0 | $31k | 414.00 | 74.88 | |
| Salix Pharmaceuticals | 0.0 | $33k | 370.00 | 89.19 | |
| Cubist Pharmaceuticals | 0.0 | $33k | 477.00 | 69.18 | |
| Medivation | 0.0 | $32k | 501.00 | 63.87 | |
| Covance | 0.0 | $33k | 375.00 | 88.00 | |
| Spectrum Pharmaceuticals | 0.0 | $38k | 4.3k | 8.84 | |
| Quintiles Transnatio Hldgs I | 0.0 | $35k | 746.00 | 46.92 |
